Abbott Laboratories (ABT)
NYSE: ABT · IEX Real-Time Price · USD
+1.13 (1.10%)
At close: Jul 11, 2024, 4:00 PM
-0.36 (-0.35%)
Pre-market: Jul 12, 2024, 5:58 AM EDT

Company Description

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.

It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories.

In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders.

Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Abbott Laboratories
Abbott Laboratories logo
Country United States
Founded 1888
Industry Medical Devices
Sector Healthcare
Employees 114,000
CEO Robert B. Ford

Contact Details

100 Abbott Park Road
Abbott Park, Illinois 60064-3500
United States
Phone (224) 667-6100

Stock Details

Ticker Symbol ABT
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000001800
CUSIP Number 002824100
ISIN Number US0028241000
Employer ID 36-0698440
SIC Code 2834

Key Executives

Name Position
Robert B. Ford Chairman of the Board, President and Chief Executive Officer
Philip P. Boudreau Chief Financial Officer and Senior Vice President of Finance
Hubert L. Allen Executive Vice President, General Counsel and Secretary
Robert E. Funck Jr. Executive Vice President of Finance
Daniel Gesua Sive Salvadori Executive Vice President and Group President of Established Pharmaceuticals and Nutritional Products
Lisa D. Earnhardt Executive Vice President and Group President of Medical Devices
Sabina Ewing Senior Vice President of Business and Technology Services and Chief Information Officer
Erica L. Battaglia Vice President and Chief Ethics and Compliance Officer
Melissa Brotz Vice President of Public Affairs and Corporate Marketing
Christopher J. Scoggins Senior Vice President of Commercial Operations, Marketing and Diabetes Care

Latest SEC Filings

Date Type Title
Jun 25, 2024 11-K Annual report of employee stock purchase, savings and similar plans
May 30, 2024 SD Form - SD
May 10, 2024 144 Filing
May 7, 2024 144 Filing
May 2, 2024 10-Q Quarterly Report
May 1, 2024 8-K Current Report
Apr 29, 2024 8-K Current Report
Apr 17, 2024 8-K Current Report
Mar 15, 2024 ARS Filing
Mar 15, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material